VCV001806259.2 - ClinVar

NM_198880.3(QRICH1):c.1245A>G (p.Ile415Met)

Germline

Classification

The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.

(2)

Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.

Uncertain significance

criteria provided, multiple submitters, no conflicts

Somatic

No data submitted for somatic clinical impact

Somatic

No data submitted for oncogenicity

Variant Details

Identifiers

NM_198880.3(QRICH1):c.1245A>G (p.Ile415Met)

Variation ID: 1806259 Accession: VCV001806259.2

Type and length

single nucleotide variant, 1 bp

Location

Cytogenetic: 3p21.31 3: 49056955 (GRCh38) [ NCBI UCSC ] 3: 49094388 (GRCh37) [ NCBI UCSC ]

Timeline in ClinVar

	First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.	Last submission Help The date of the most recent submission for each type of classification for this variant.	Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline	Dec 24, 2022	Aug 11, 2024	May 17, 2024

HGVS

Nucleotide	Protein	Molecular consequence
NM_198880.3:c.1245A>G MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.	NP_942581.1:p.Ile415Met	missense
NM_001320580.2:c.1245A>G	NP_001307509.1:p.Ile415Met	missense
NM_001320581.2:c.1245A>G	NP_001307510.1:p.Ile415Met	missense
NM_001320582.2:c.1245A>G	NP_001307511.1:p.Ile415Met	missense
NM_001320583.2:c.1245A>G	NP_001307512.1:p.Ile415Met	missense
NM_001320584.1:c.1245A>G	NP_001307513.1:p.Ile415Met	missense
NM_001320585.1:c.1245A>G	NP_001307514.1:p.Ile415Met	missense
NM_017730.4:c.1245A>G	NP_060200.2:p.Ile415Met	missense
NC_000003.12:g.49056955T>C
NC_000003.11:g.49094388T>C

... more HGVS ... less HGVS

Protein change

I415M

Other names

Canonical SPDI

NC_000003.12:49056954:T:C

Functional consequence Help The effect of the variant on RNA or protein function, based on experimental evidence from submitters.

Global minor allele frequency (GMAF) Help The global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.

Allele frequency Help The frequency of the allele represented by this VCV record.

Links

VarSome

Genes

Gene	OMIM	ClinGen Gene Dosage Sensitivity Curation		Variation Viewer Help Links to Variation Viewer, a genome browser to view variation data from NCBI databases.	Related variants
Gene	OMIM	HI score Help The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.	TS score Help The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.		Within gene Help The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants.	All Help The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene.
QRICH1		Sufficient evidence for dosage pathogenicity	No evidence available	GRCh38 GRCh37	155	170

Conditions - Germline

Condition Help The condition for this variant-condition (RCV) record in ClinVar.	Classification Help The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions)	Review status Help The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status.	Last evaluated Help The most recent date that a submitter evaluated this variant for the condition.	Variation/condition record Help The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page.
Ververi-Brady syndrome	Uncertain significance (1)	criteria provided, single submitter	May 21, 2020	RCV002470543.1
not specified	Uncertain significance (1)	criteria provided, single submitter	May 17, 2024	RCV004690298.1

Submissions - Germline

Classification Help The submitted germline classification for each SCV record. (Last evaluated)	Review status Help Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria)	Condition Help The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant.	Submitter Help The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar.	More information Help This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter.
Uncertain significance (May 21, 2020)	criteria provided, single submitter (ACMG Guidelines, 2015) Method: clinical testing	Ververi-Brady syndrome (Autosomal dominant inheritance) Affected status: yes Allele origin: germline	Victorian Clinical Genetics Services, Murdoch Childrens Research Institute Additional submitter: Shariant Australia, Australian Genomics Accession: SCV002768693.1 First in ClinVar: Dec 24, 2022 Last updated: Dec 24, 2022	Comment: A heterozygous missense variant was identified, NM_017730.3(QRICH1):c.1245A>G in exon 4 of 11 of the QRICH1 gene. This substitution is predicted to create a minor amino … (more) A heterozygous missense variant was identified, NM_017730.3(QRICH1):c.1245A>G in exon 4 of 11 of the QRICH1 gene. This substitution is predicted to create a minor amino acid change from isoleucine to methionine at position 415 of the protein, NP_060200.2(QRICH1):p.(Ile415Met). The isoleucine at this position has high conservation (100 vertebrates, UCSC), but is not situated in a known functional domain. In silico software predicts this variant to be pathogenic (PolyPhen, SIFT, CADD, MutationTaster). The variant is present in the gnomAD population database at a frequency of 0.0004% (1 heterozygote; 0 homozygotes). An alternative change to valine at the same residue has also been reported in the gnomAD database at a frequency of 0.0004%. The variant has not previously been reported in clinical cases. Subsequent analysis of parental samples indicated that this variant was paternally inherited. Based on information available at the time of curation, this variant has been classified as a VARIANT of UNCERTAIN SIGNIFICANCE (VUS) with LOW CLINICAL RELEVANCE. (less)
Uncertain significance (May 17, 2024)	criteria provided, single submitter (LabCorp Variant Classification Summary - May 2015) Method: clinical testing	not specified Affected status: unknown Allele origin: germline	Women's Health and Genetics/Laboratory Corporation of America, LabCorp Accession: SCV005185592.1 First in ClinVar: Aug 11, 2024 Last updated: Aug 11, 2024	Comment: Variant summary: QRICH1 c.1245A>G (p.Ile415Met) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign … (more) Variant summary: QRICH1 c.1245A>G (p.Ile415Met) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251416 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.1245A>G in individuals affected with Ververi-Brady Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 1806259). Based on the evidence outlined above, the variant was classified as uncertain significance. (less)

Comment:

A heterozygous missense variant was identified, NM_017730.3(QRICH1):c.1245A>G in exon 4 of 11 of the QRICH1 gene. This substitution is predicted to create a minor amino acid change from isoleucine to methionine at position 415 of the protein, NP_060200.2(QRICH1):p.(Ile415Met). The isoleucine at this position has high conservation (100 vertebrates, UCSC), but is not situated in a known functional domain. In silico software predicts this variant to be pathogenic (PolyPhen, SIFT, CADD, MutationTaster). The variant is present in the gnomAD population database at a frequency of 0.0004% (1 heterozygote; 0 homozygotes). An alternative change to valine at the same residue has also been reported in the gnomAD database at a frequency of 0.0004%. The variant has not previously been reported in clinical cases. Subsequent analysis of parental samples indicated that this variant was paternally inherited. Based on information available at the time of curation, this variant has been classified as a VARIANT of UNCERTAIN SIGNIFICANCE (VUS) with LOW CLINICAL RELEVANCE.

Comment:

Variant summary: QRICH1 c.1245A>G (p.Ile415Met) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251416 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.1245A>G in individuals affected with Ververi-Brady Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 1806259). Based on the evidence outlined above, the variant was classified as uncertain significance.

Germline Functional Evidence

There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar.

Comment:

Citations for germline classification of this variant

There are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar.

Text-mined citations for this variant ...

Record last updated Aug 18, 2024

ClinVar Genomic variation as it relates to human health

NM_198880.3(QRICH1):c.1245A>G (p.Ile415Met)

Variant Details

Genes

Conditions - Germline

Submissions - Germline

Germline Functional Evidence

Citations for germline classification of this variant

Text-mined citations for this variant ...